High early mortality in idiopathic inflammatory myopathies: results from the inception cohort at a tertiary care centre in northern India.

Indian patients with IIM suffer high early mortality attributable to infection, cancer and RP-ILD, calling for high vigilance post diagnosis. Autoantibodies and certain clinical features identify risk for composite adverse outcomes.